incretin
Small moleculeexperimental
Incretins are a group of metabolic hormones that decrease blood glucose levels. Incretins are released after eating and augment the secretion of insulin released from pancreatic beta cells of the islets of Langerhans by a blood-glucose–dependent mechanism. — Wikipedia
Clinical trial activity
7 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
5
Earliest trial started Oct 1, 2012 (NCT01681550)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIncretin ↗
Also known as
- incretin
- incretin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06374875 | Phase 4 | Jul 11, 2024 | The Cleveland Clinic |
| NCT03360981 | Phase 4 | Sep 20, 2017 | University of Campania Luigi Vanvitelli |
| NCT03282136 | Phase 4 | Sep 1, 2017 | University of Campania Luigi Vanvitelli |
| NCT02244164 | N/A | Oct 1, 2014 | Erasmus University Rotterdam |
| NCT02041234 | Phase 4 | Feb 1, 2014 | Khoo Teck Puat Hospital |
| NCT02029846 | Phase 4 | Apr 1, 2013 | Johns Hopkins University |
| NCT01681550 | N/A | Oct 1, 2012 | Nagaoka Red Cross Hospital |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Campania Luigi Vanvitelli | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Erasmus University Rotterdam | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Khoo Teck Puat Hospital | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Nagaoka Red Cross Hospital | Academic/Hospital | 1 | 1 | 1 | 2012 |
| The Cleveland Clinic | Academic/Hospital | 1 | 1 | 1 | 2024 |
6 organizations
Page 1 / 1